Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBloomsbury Regulatory News (BMY)

Share Price Information for Bloomsbury (BMY)

Share Price is delayed by 15 minutes
Get Live Data
623.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 4.00 (0.641%)
Market Cap: £503.65m
BMY Live PriceLast checked at - London Stock Exchange

Intraday Bloomsbury Share Chart

Director/PDMR Shareholding

10 Aug 2022 17:22

RNS Number : 6226V
Bloomsbury Publishing PLC
10 August 2022
Β 

10 August 2022

Β 

Bloomsbury Publishing Plc (the "Company")

Β 

Director/PDMR Shareholdings

Β 

Awards under the Bloomsbury Publishing Plc 2014 Performance Share Plan ("2014 PSP")

Β 

On 10 August 2022, PSP conditional share awards under the 2014 PSP were granted to two PDMRs and members of senior management over ordinary shares of 1.25 pence in the Company (the "PSP Awards").

Β 

The PSP Awards were granted at a price per share of Β£4.18, based on the closing mid-market price of a share on 9 August 2022.

Β 

Performance conditions

Β 

The PSP Award is based on performance measured over the three financial years ending February 2025, with straight-line vesting between the points shown in the table below. Awards to Executive Directors will also be subject to a post-vesting holding period of two years.

The PSP Awards are subject to the following performance targets:

Metric

Weighting

0% vesting

25% vesting

100% vesting

EPS (before highlighted items)

60%

28.7p

30.2p

35.4p

Non-Consumer Operating Profit

15%

Β£9.8m

Β£10.9m

Β£14.3m

Consumer Operating Profit

15%

Β£18.1m

Β£20.0m

Β£25.8m

Bloomsbury Digital Resources Revenue

10%

Β£22.3m

Β£24.3m

Β£30.3m

Β 

Notifications

Β 

The relevant notifications set out below are provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation.

Β 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Nigel Newton

2

Reason for the notification

a)

Position/status

Chief Executive

b)

Β 

Initial notification /Amendment

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Bloomsbury Publishing PLC

b)

LEI

213800ZL2PEC4C6UOQ53

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Β 

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 1.25p Each

Β 

Β 

ISIN:Β GB0033147751

b)

Nature of the transaction

Grant of PSP awards under the Bloomsbury Publishing Plc 2014 Performance Share Plan subject to performance conditions

c)

Price(s) and volume(s)

Price

No. of shares

418p

118,957

d)

Aggregated information

N/A

e)

Date of the transaction

10 August 2022

f)

Place of the transaction

Grant of the options occurred outside a trading venue

Β 

Β 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Penny Scott-Bayfield

2

Reason for the notification

a)

Position/status

Group Finance Director

b)

Β 

Initial notification /Amendment

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Bloomsbury Publishing PLC

b)

LEI

213800ZL2PEC4C6UOQ53

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Β 

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 1.25p Each

Β 

Β 

ISIN:Β GB0033147751

b)

Nature of the transaction

Grant of PSP awards under the Bloomsbury Publishing Plc 2014 Performance Share Plan subject to performance conditions

c)

Price(s) and volume(s)

Price

No. of shares

418p

74,303

d)

Aggregated information

N/A

e)

Date of the transaction

10 August 2022

f)

Place of the transaction

Grant of the options occurred outside a trading venue

Β 

Β 

Β 

For further information, please contact:

Bloomsbury Publishing Plc

Maya Abu-Deeb, Group General Counsel & Company Secretary

maya.abu-deeb@bloomsbury.com

Hudson Sandler

+44 (0) 20 7796 4133

Dan de Belder / Hattie Dreyfus

bloomsbury@hudsonsandler.com

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHBLGDIRBBDGDG
Date   Source Headline
15th May 20257:00 amRNSNotice of Preliminary Results
15th Apr 20257:00 amRNSAppointment of Joint Corporate Broker
20th Mar 20257:00 amRNSTrading Update and Board Appointment
3rd Mar 20257:00 amRNSNotice of Trading Update
24th Feb 20254:27 pmRNSHolding(s) in Company
14th Feb 202510:05 amRNSBLOCK LISTING SIX MONTHLY RETURN
24th Jan 20257:00 amRNSBloomsbury reaches new agreement with Amazon
16th Dec 202410:05 amRNSHolding(s) in Company
16th Dec 20249:55 amRNSHolding(s) in Company - Replacement
11th Dec 202410:24 amRNSDirector/PDMR Shareholding
9th Dec 20249:18 amRNSDirector/PDMR Shareholding
26th Nov 202411:44 amRNSHolding(s) in Company
26th Nov 202410:35 amRNSDirector/PDMR Shareholding
24th Oct 20247:00 amRNSUnaudited Interim Results
30th Sep 20247:00 amRNSNotice of Interim Results
2nd Sep 202411:31 amRNSDirector/PDMR Shareholding
29th Aug 20247:00 amRNSDirector/PDMR Shareholding
28th Aug 202410:57 amRNSDirector/PDMR Shareholding
16th Aug 20244:18 pmRNSAMENDMENT: BLOCK LISTING SIX MONTHLY RETURN
16th Aug 20249:42 amRNSBLOCK LISTING SIX MONTHLY RETURN
7th Aug 20245:36 pmRNSAwards under the 2023 Executive Share Plan
16th Jul 20243:41 pmRNSResults of the 2024 Annual General Meeting
16th Jul 20247:00 amRNSAGM Trading Update
14th Jun 20245:01 pmRNSAnnual Financial Report
14th Jun 20241:48 pmRNSBoard Appointment
29th May 20247:00 amRNSAcquisition
23rd May 20247:00 amRNSChairman Succession Announcement
23rd May 20247:00 amRNSAudited Preliminary Results
20th May 20247:00 amRNSInvestor Presentation
16th Feb 20247:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
14th Feb 20247:00 amRNSTrading Update
1st Feb 20243:11 pmRNSBloomsbury launches latest Sarah J. Maas novel
15th Jan 20247:00 amRNSBloomsbury Appoints Head of Investor Relations
12th Jan 202411:45 amRNSHolding(s) in Company
9th Jan 20244:10 pmRNSDirector/PDMR Shareholding
7th Dec 20237:00 amRNSTrading Update
15th Nov 20237:00 amRNSBlocklisting Application
31st Oct 20237:00 amRNSInvestor Presentation
26th Oct 20237:00 amRNSUnaudited Interim Results
9th Oct 20231:00 pmRNSBloomsbury playwright Jon Fosse wins Nobel Prize
22nd Sep 20231:26 pmRNSDirector/PDMR Shareholdings - Correction
14th Sep 20237:00 amRNSBloomsbury launches new book by Katherine Rundell
5th Sep 20237:00 amRNSDirector/PDMR Shareholding
1st Sep 20232:05 pmRNSDirector/PDMR Shareholding
30th Aug 20231:56 pmRNSDirector/PDMR Shareholding
29th Aug 20232:11 pmRNSDirector/PDMR Shareholding
23rd Aug 20237:00 amRNSHolding(s) in Company
22nd Aug 20238:00 amRNSBloomsbury enjoys bestseller success
17th Aug 20234:40 pmRNSBLOCK LISTING SIX MONTHLY RETURN
18th Jul 20235:13 pmRNSResults of the 2023 Annual General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.